NYSE Euronext plans to ramp up its challenge to CME Group by introducing several interest-rate derivatives this year. Tom Callahan, CEO of NYSE Liffe U.S., said the company plans to increase its share of the Eurodollar futures market from 3% to 10% during the next year. "The core mission is first to establish ourselves as a viable competitor to CME," Callahan said.

Related Summaries